Key facts
- Kyberlife’s last known valuation is $9.8M (Mar 2023).
- It has raised $4.1M; the latest was Later Stage VC ($3.0M) in Mar 2025.
- Notable investors include East Ventures, 5i Ventures, A2D Ventures, Amatar Investment, Bernd Lepper — 22 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 22 names
- ·Watchlist + deal alerts for Kyberlife
- ·The full record, as it builds
Funding rounds
No funding rounds for Kyberlife are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kyberlife
Developer of a procurement platform designed to provide an open marketplace for medical and life-science products. The company's platform facilitates searches, purchases, and communication between vendors and customers, hosting a diverse catalog of authenticated instruments, pharmaceuticals, and equipment, enabling healthcare organizations to access, compare, and procure verified supplies efficiently.
- Sector
- Healthcare
- HQ
- Singapore, Singapore
- Founded
- 2020
- Employees
- 26
- Website
- kyberlife.com/
- Ownership
- Privately Held (backing)
Kyberlife doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kyberlife shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kyberlife in its N-PORT filings yet. We sweep new filings monthly.